{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:44:05Z","timestamp":1782913445541,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04184-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:01:28Z","timestamp":1751374888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves\u2019 orbitopathy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-5296","authenticated-orcid":false,"given":"Hedayatullah","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-2310","authenticated-orcid":false,"given":"\u0130rfan Botan","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyhmus","family":"Ar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"8","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362(8):726\u201338. https:\/\/doi.org\/10.1056\/NEJMra0905750.","journal-title":"N Engl J Med"},{"key":"4184_CR2","doi-asserted-by":"publisher","first-page":"615993","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, et al. Epidemiology, natural history, risk factors, and prevention of graves\u2019 orbitopathy. Front Endocrinol (Lausanne). 2020;11:615993. https:\/\/doi.org\/10.3389\/fendo.2020.615993. Published 2020 Nov 30.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cen.14681","volume":"96","author":"J Furmaniak","year":"2022","unstructured":"Furmaniak J, Sanders J, Sanders P, et al. TSH receptor-specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with graves\u2019 disease and graves\u2019 orbitopathy-Results from a phase I clinical trial. Clin Endocrinol (Oxf). 2022;96(6):878\u201387. https:\/\/doi.org\/10.1111\/cen.14681.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4184_CR4","doi-asserted-by":"publisher","unstructured":"Diana T, Ponto KA, Kahaly GJ. Thyrotropin receptor antibodies and Graves\u2019 orbitopathy [published correction appears in J Endocrinol Invest. 2022;45(1):233]. J Endocrinol Invest. 2021;44 (4):703\u2013712. https:\/\/doi.org\/10.1007\/s40618-020-01380-9","DOI":"10.1007\/s40618-020-01380-9"},{"issue":"5","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","volume":"22","author":"PJ Dolman","year":"2006","unstructured":"Dolman PJ, Rootman J. VISA classification for graves orbitopathy. Ophthalmic Plast Reconstr Surg. 2006;22(5):319\u201324. https:\/\/doi.org\/10.1097\/01.iop.0000235499.34867.85.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4184_CR6","doi-asserted-by":"publisher","unstructured":"European Group on Graves\u2019 Orbitopathy (EUGOGO), Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, Boschi A, Dickinson AJ, Kendall-Taylor P, Krassas GE et al. Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists, and clinical researchers. Eur J Endocrinol 2006:155 (3):387\u20139. https:\/\/doi.org\/10.1530\/eje.1.02230","DOI":"10.1530\/eje.1.02230"},{"issue":"4","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9394(69)91246-x","volume":"68","author":"SC Werner","year":"1969","unstructured":"Werner SC. Classification of the eye changes of graves\u2019 disease. Am J Ophthalmol. 1969;68(4):646\u20138. https:\/\/doi.org\/10.1016\/0002-9394(69)91246-x.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4184_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40123-019-00226-9","volume":"9","author":"NM Hodgson","year":"2020","unstructured":"Hodgson NM, Rajaii F. Current Understanding of the progression and management of thyroid associated orbitopathy: a systematic review. Ophthalmol Therapy. 2020;9(1):21\u201333. https:\/\/doi.org\/10.1007\/s40123-019-00226-9.","journal-title":"Ophthalmol Therapy"},{"issue":"5","key":"4184_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICU.0b013e3283499446","volume":"22","author":"RS Douglas","year":"2011","unstructured":"Douglas RS, Gupta S. The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr Opin Ophthalmol. 2011;22(5):385\u201390. https:\/\/doi.org\/10.1097\/ICU.0b013e3283499446.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"4184_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.47391\/JPMA.22-28","volume":"72","author":"DE Kurian","year":"2022","unstructured":"Kurian DE, Kalra S, Kapoor N. Understanding the pathogenesis of graves\u2019 orbitopathy: A new age paradigm. J Pak Med Assoc. 2022;72(4):767\u201370. https:\/\/doi.org\/10.47391\/JPMA.22-28.","journal-title":"J Pak Med Assoc"},{"issue":"63","key":"4184_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15557\/JoU.2015.0036","volume":"15","author":"D Walasik-Szempli\u0144ska","year":"2015","unstructured":"Walasik-Szempli\u0144ska D, Pauk-Doma\u0144ska M, Sanocka U, et al. Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy. J Ultrasonography. 2015;15(63):388.","journal-title":"J Ultrasonography"},{"issue":"11","key":"4184_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/02713680701689773","volume":"32","author":"P Perri","year":"2007","unstructured":"Perri P, Campa C, Costagliola C, et al. Increased retinal blood flow in patients with active graves\u2019 ophthalmopathy. Curr Eye Res. 2007;32(11):985\u201390. https:\/\/doi.org\/10.1080\/02713680701689773.","journal-title":"Curr Eye Res"},{"issue":"12","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1055\/a-1654-0504","volume":"238","author":"B Hohberger","year":"2021","unstructured":"Hohberger B, Mardin CY. OCT angiography as an interdisciplinary diagnostic tool for systemic diseases. Klin Monbl Augenheilkd. 2021;238(12):1294\u20138. https:\/\/doi.org\/10.1055\/a-1654-0504.","journal-title":"Klin Monbl Augenheilkd"},{"key":"4184_CR14","doi-asserted-by":"publisher","unstructured":"Mourits MP, Prummel MF, Wiersinga WM et al. (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy [published correction appears in Clin Endocrinol (Oxf) 1997;47(5):632]. Clin Endocrinol (Oxf) 47(1):9\u201314. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.2331047.x","DOI":"10.1046\/j.1365-2265.1997.2331047.x"},{"key":"4184_CR15","doi-asserted-by":"publisher","unstructured":"Lo C, Ugradar S, Rootman D. Management of graves myopathy: Orbital imaging in thyroid-related orbitopathy. J AAPOS. 2018;22 (4):256.e1-256.e9. https:\/\/doi.org\/10.1016\/j.jaapos.2018.06.002","DOI":"10.1016\/j.jaapos.2018.06.002"},{"issue":"10","key":"4184_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jfo.2013.07.004","volume":"36","author":"B Leray","year":"2013","unstructured":"Leray B, Imbert P, Thouvenin D, et al. Prise En charge diagnostique et th\u00e9rapeutique d\u2019une orbitopathie dysthyro\u00efdienne: Une affection multidisciplinaire [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease]. J Fr Ophtalmol. 2013;36(10):874\u201385. https:\/\/doi.org\/10.1016\/j.jfo.2013.07.004.","journal-title":"J Fr Ophtalmol"},{"issue":"7","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1167\/iovs.16-21389","volume":"58","author":"T Tani","year":"2017","unstructured":"Tani T, Song YS, Yoshioka T, et al. Repeatability and reproducibility of retinal blood flow measurement using a doppler optical coherence tomography flowmeter in healthy subjects. Invest Ophthalmol Vis Sci. 2017;58(7):2891\u20138. https:\/\/doi.org\/10.1167\/iovs.16-21389.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4184_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European group on graves\u2019 orbitopathy (EUGOGO) on the management of GO. Eur J Endocrinol. 2008;158:273\u201385.","journal-title":"Eur J Endocrinol"},{"key":"4184_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European thyroid association\/european group on graves\u2019 orbitopathy guidelines for the management of graves\u2019 orbitopathy. Eur Thyroid J. 2016;5:9\u201326.","journal-title":"Eur Thyroid J"},{"key":"4184_CR20","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1055\/s-0029-1243057","volume":"134","author":"KA Ponto","year":"2009","unstructured":"Ponto KA, Pitz S, Mann WJ, et al. [Management of graves\u2019 orbitopathy: evidence-based recommendations]. Dtsch Med Wochenschr. 2009;134:2521\u20134.","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"4184_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/197140091302600509","volume":"26","author":"F Tortora","year":"2013","unstructured":"Tortora F, Cirillo M, Ferrara M, et al. Disease activity in graves\u2019 ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. Neuroradiol J. 2013;26(5):555\u201364. https:\/\/doi.org\/10.1177\/197140091302600509.","journal-title":"Neuroradiol J"},{"issue":"1","key":"4184_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imj.15067","volume":"52","author":"AJH Hall","year":"2022","unstructured":"Hall AJH, Topliss DJ. Medical and surgical treatment of thyroid eye disease. Intern Med J. 2022;52(1):14\u201320. https:\/\/doi.org\/10.1111\/imj.15067.","journal-title":"Intern Med J"},{"issue":"11","key":"4184_CR23","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00417-019-04442-8","volume":"257","author":"M Jamshidian Tehrani","year":"2019","unstructured":"Jamshidian Tehrani M, Mahdizad Z, Kasaei A, et al. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2019;257(11):2533\u201340.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4184_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01676830.2020.1846761","volume":"17","author":"TV Dave","year":"2020","unstructured":"Dave TV, Laghmisetty S, Krishnamurthy G, Bejjanki K, Ganguly A, Jonnadula GB, Dave VP, Reddy Pappuru R. Retinal vascularity, nerve fiber, and ganglion cell layer thickness in thyroid eye disease on optical coherence tomography angiography. Orbit (Amsterdam Netherlands). 2020;17:1\u20138. https:\/\/doi.org\/10.1080\/01676830.2020.1846761.","journal-title":"Orbit (Amsterdam Netherlands)"},{"key":"4184_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40662-020-00180-9","volume":"7","author":"Y Wu","year":"2020","unstructured":"Wu Y, Tu Y, Wu C, et al. Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy. Eye Vis (Lond). 2020;7:16. https:\/\/doi.org\/10.1186\/s40662-020-00180-9. Published 2020 Mar 10.","journal-title":"Eye Vis (Lond)"},{"issue":"7","key":"4184_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4158\/EP-2017-0229","volume":"24","author":"L Ye","year":"2018","unstructured":"Ye L, Zhou SS, Yang WL, et al. Retinal microvasculature alteration in active thyroid-associated ophthalmopathy. Endocr Pract. 2018;24(7):658\u201367. https:\/\/doi.org\/10.4158\/EP-2017-0229.","journal-title":"Endocr Pract"},{"issue":"2","key":"4184_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00417-021-05336-4","volume":"260","author":"C Del Noce","year":"2022","unstructured":"Del Noce C, Roda M, Ferro Desideri L, et al. Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT. Graefes Arch Clin Exp Ophthalmol. 2022;260(2):571\u20136. https:\/\/doi.org\/10.1007\/s00417-021-05336-4. Epub 2021 Sep 1. PMID: 34468829; PMCID: PMC8786772.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"4184_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ophtha.2021.03.036","volume":"128","author":"A Kamalipour","year":"2021","unstructured":"Kamalipour A, Moghimi S, Hou H, et al. OCT angiography artifacts in Glaucoma. Ophthalmology. 2021;128(10):1426\u201337. https:\/\/doi.org\/10.1016\/j.ophtha.2021.03.036.","journal-title":"Ophthalmology"},{"issue":"3\u20134","key":"4184_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.vph.2009.09.004","volume":"52","author":"T Ichiki","year":"2010","unstructured":"Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol. 2010;52(3\u20134):151\u20136.","journal-title":"Vascul Pharmacol"},{"key":"4184_CR30","doi-asserted-by":"publisher","first-page":"796194","DOI":"10.3389\/fendo.2021.796194","volume":"12","author":"W Wisnu","year":"2021","unstructured":"Wisnu W, Alwi I, Nafrialdi N, Harimurti K, Pemayun TGD, Jusman SWA, Santoso DIS, Harahap AR, Suwarto S, Subekti I. The differential effects of propylthiouracil and methimazole as graves\u2019 disease treatment on vascular atherosclerosis markers: A randomized clinical trial. Front Endocrinol (Lausanne). 2021;12:796194.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4184_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.preteyeres.2008.02.002","volume":"27","author":"CJ Pournaras","year":"2008","unstructured":"Pournaras CJ, Rungger-Br\u00e4ndle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res. 2008;27(3):284\u2013330. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.02.002.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"4184_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/17434440.2018.1548932","volume":"15","author":"M Arya","year":"2018","unstructured":"Arya M, Rashad R, Sorour O, Moult EM, Fujimoto JG, Waheed NK. Optical coherence tomography angiography (OCTA) flow speed mapping technology for retinal diseases. Expert Rev Med Devices. 2018;15(12):875\u201382. https:\/\/doi.org\/10.1080\/17434440.2018.1548932.","journal-title":"Expert Rev Med Devices"},{"issue":"4","key":"4184_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5301\/ejo.5000419","volume":"24","author":"E Lee","year":"2014","unstructured":"Lee E, Harris A, Siesky B, et al. The influence of retinal blood flow on open-angle glaucoma in patients with and without diabetes. Eur J Ophthalmol. 2014;24(4):542\u20139. https:\/\/doi.org\/10.5301\/ejo.5000419.","journal-title":"Eur J Ophthalmol"},{"key":"4184_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1076\/0927-3972(200009)831-ZFT187","volume":"8","author":"K Hartmann","year":"2000","unstructured":"Hartmann K, Meyerschwickerath R. Measurement of venous outflow pressure in the central retinal vein to evaluate intraorbital pressure in graves\u2019 ophthalmopathy: a preliminary report. Strabismus. 2000;8:187\u201393.","journal-title":"Strabismus"},{"key":"4184_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00417-009-1144-0","volume":"247","author":"O Konuk","year":"2009","unstructured":"Konuk O, Onaran Z, Ozhan OS, et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in graves\u2019 orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247:1555\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4184_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000055622","volume":"32","author":"C Delaey","year":"2000","unstructured":"Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000;32:249\u201356.","journal-title":"Ophthalmic Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04184-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:19Z","timestamp":1751418319000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04184-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the present study, approval was obtained from the Local Ethics Committee for Clinical Practices of Gaziantep University (Reg. number: 07\/25\/2021\u2009\u2212\u2009205) under the 1961 Declaration of Helsinki and its later amendments. Informed consent was obtained from all individual participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}